Crystal Pharmatech Formulation Forum - Crystal Pharmatech Co., Ltd.

We proudly announce the Crystal Pharmatech Formulation Forum, providing an educational platform with monthly webinars for fellow formulators and the pharmaceutical industry as a whole.

From these monthly webinars, we offer scientists and innovators access to:

Presentations by leading formulators from different organizations and academia throughout the industry
Live sessions to ask questions and engage with presenters
Dialogue between experts to dive deep into complex subject matter

Crystal Pharmatech Formulation Forum

Solid Form Landscape to Formulation Strategy: The Role of Computational Screening and Risk Assessment

Unexpected polymorphs can upend formulation by shifting solubility, stability, and manufacturability.This webinar shows how in silico crystal structure prediction (CSP), paired with competing-form ris...

2:00-3:00 pm ET, Wednesday, November 19, 2025



Crystal Pharmatech Formulation Forum

Applying PBPK and PBBM Across R&D: From Early Insights to Formulation

Applying PBPK and PBBM Across R&D: FromEarly Insights to FormulationDrug-delivery programs face recurring hurdles: frequent dosing, nighttimecoverage, and site-specific absorption. Controlled- and...

2:00-3:00 PM ET, Wednesday, September 24, 2025



Crystal Pharmatech Formulation Forum

Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development

Drug delivery challenges include frequent dosing, nighttime administration, and site-specific absorption needs. Controlled and modified-release technologies help improve bioavailability, compliance, a...

2:00-3:00 PM ET, Wednesday, June 4, 2025



Crystal Pharmatech Formulation Forum

Drug Delivery and Patient Centric Approaches to Drug Development

Date: 2:00-3:00 pm ET, Wednesday, March 19, 2025



Crystal Pharmatech Formulation Forum

Formulation Design and Development of Fixed Dose Combination Solid Oral Dosage Forms

Featured Guest SpeakerLarry Rosen, Ph.D.Founder and Principal Consultant of Pharmalar Consulting LLCFixed Dose Combination (FDC) products are widely used in the treatment of chronic and infectious dis...

Date: 2:00-3:00 pm EST, Wednesday, January 22, 2025



Crystal Pharmatech Formulation Forum

Assessment of Powder Segregation in Direct Compression (DC) Blends: Developing Predictive and PAT Tools

This month's Formulation Forum webinar will feature Prajwal Thool from Genentech as he presents "Assessment of Powder Segregation in Direct Compression (DC) Blends: Developing Predictive and ...

Date: 2:00-3:00 pm EDT, Wednesday, November 20, 2024



Crystal Pharmatech Formulation Forum

Unlocking the Power of AI in Pharmaceutical Development

We're excited to announce September's Formulation Forum, featuring co-speakers Kevin Bittorf, Ph.D., and Keith Parent on September 25th. Kevin and Keith will detail the power of AI in pharmaceutical development.

Date: 2:00-3:00 pm EDT, Wednesday, Sep 25, 2024



Crystal Pharmatech Formulation Forum

Utilizing Compaction Simulation for Advancing Oral Dosage Formulation Design

Date: 2:00-3:00 pm EDT, Wednesday, August 21, 2024



Crystal Pharmatech Formulation Forum

Overcoming Bioavailability Barrier to Deliver Protein Degraders

Speaker: Dr. Chong-Hui Gu, Head of CMC and QA, Foghorn Therapeutics

Protein degraders offer a new opportunity to address targets that were previously undruggable. However, oral bioavailability issues have limited the use of this modality. This talk will address the factors that limit oral absorption and approaches to overcome those issues. This talk will also overview other delivery options to deliver protein degraders such as long acting injectable formulations.

Date: 2:00-3:00 pm EDT, Wednesday, July 24, 2024



Crystal Pharmatech Formulation Forum

Amorphous Solid Dispersions: Two Heads Are Better Than One

Speaker: Dr. Na Li, Assistant Professor in Pharmaceutical Sciences at the University of Connecticut

Amorphous solid dispersion is an important formulation strategy used to overcome a drug’s poor solubility and boost bioavailability. Through molecular mixing with a polymer in the amorphous state, the drug’s dissolution rate is greatly enhanced. This does not only lead to increased free drug concentration in solution, but also sometimes the generation of amorphous drug nanoparticles.

Date: 2:00-3:00 pm EDT, Wednesday, May 8, 2024



Crystal Pharmatech Formulation Forum

Overcoming Poor Solubility and Dissolution of Insoluble Molecules

Speaker: Dr. Sudhakar Garad, Novartis

Dosage form (formulation) and enabling technologies play a vital role for the success of new chemical entities transitioning from preclinical to clinical development through commercialization.

Date: 2:00-3:00 pm EDT, Wednesday, April 17, 2024

